Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Jan 15 update - patient data impressions

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Jan 15, 2024 3:08pm

353 Views

Post# 35827548

Jan 15 update - patient data impressions

For those of us who like to follow swimmer's plots and what they tell us, see the bottom of this post for an update on the evolution of patients compared to Nov 29.

Overall impression is that most of the probabilities stay about the same.

I think the reason for the release is the 2 new patients arriving at 450 days as CR. They thought that this would be a positive bump. It is, but not enought that changes the probabilities too much. Ruvidar still works extremely, especially well for the number of treatments.

With the new Health Canada update, 5 patients now qualify for a retreatment to try and get them back to CR after having changed to NR in the most recent swimmers plot.

At this time there is no wave of green CR's washing from left to right. Just some CRs at 270 and 360 to play out. So far we still have the pattern that all 360 day continuous CR's stay that way by 450 so there are two more imminent 450 day CR's coming.

There is nothing more that will shift the percentages by much in the coming months. If the BTD application depends on things that they are trying to chase down, it would be details about the patients presented up to this point.